Joe Garcia

Company: Aqualung Therapeutics Corp.

Job title: Founder and Chief Executive Officer

Seminars:

Workshop C Comparatively Assess Novel & Disease- Specific Targets vs. Upstream Broad-Spectrum Targets to Unveil Untapped Opportunities for Enhanced IPF Therapeutics 11:30 am

• Exploring specific and isolated drivers of IPF including ECM, fibroblasts, macrophages, epithelial and endothelial cells as opposed to generic processes • Minimizing off target effects with novel disease-specific pathways and targets to halt fibrosis with greater precision • Targeting upstream non-specific processes affecting multiple downstream pro-fibrotic pathways • Finding the balance between strength and…Read more

day: Pre-Conference Workshop C